Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SAES Getters is an Italian industrial group specializing in advanced materials and technology, with a historically significant presence in the healthcare sector through its medical device component business. The company was a global leader in the production of Nitinol (nickel-titanium) shape memory alloys, which are essential for minimally invasive medical devices such as stents, heart valves, and orthodontic wires. In 2023, SAES Getters completed the sale of its core Nitinol medical business, including subsidiaries Memry Corporation and SAES Smart Materials, to Resonetics for approximately $900 million. Despite this divestiture, the company remains an active player in high-tech materials science and continues to provide specialized components and vacuum technology for various industrial and scientific applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SAES Devices.